B-Cell-Deficient and CD8 T-Cell-Depleted Gnotobiotic Pigs for the Study of Human Rotavirus Vaccine-Induced Protective Immune Responses.

Genetically modified pigs have become available recently. In this study, we established the gnotobiotic pig model of human rotavirus (HRV) infection using cloned pigs with homozygous disruption in the gene encoding immunoglobulin heavy chain (HCKO), which totally impairs B-cell development. To clarify importance of B cells and cytotoxic T cells in rotavirus immunity, CD8 cells in a subset of the pigs were depleted by injecting antipig CD8 antibodies and the immune phenotypes of all pigs were examined. HCKO pigs, CD8 cell-depleted HCKO pigs, and wild-type (WT) pigs were vaccinated with an attenuated HRV vaccine and challenged with virulent HRV. Protection against HRV infection and diarrhea was assessed postchallenge and detailed T-cell subset responses were determined pre- and postchallenge. Significantly longer duration of virus shedding was seen in vaccinated HCKO pigs than in WT pigs, indicating the importance of B cells in vaccine-induced protective immunity. Vaccinated HCKO/CD8(-) pigs shed significantly higher number of infectious virus than WT pigs and non-CD8-depleted HCKO pigs, indicating the importance of CD8 T cells in controlling virus replication. Therefore, both B cells and CD8 T cells play an important role in the protection against rotavirus infection. HCKO and HCKO/CD8(-) pigs did not differ significantly in diarrhea and virus shedding postchallenge; increased CD4 and CD8(-) γδ T-cell responses probably compensated partially for the lack of CD8 T cells. This study demonstrated that HCKO pigs can serve as a valuable model for dissection of protective immune responses against viral infections and diseases.

[1]  R. Roberts,et al.  Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency , 2014, Proceedings of the National Academy of Sciences.

[2]  M. Ohtsuka,et al.  The combinational use of CRISPR/Cas9‐based gene editing and targeted toxin technology enables efficient biallelic knockout of the α‐1,3‐galactosyltransferase gene in porcine embryonic fibroblasts , 2014, Xenotransplantation.

[3]  Lijuan Yuan,et al.  Dual Functions of Lactobacillus acidophilus NCFM as Protection Against Rotavirus Diarrhea , 2014, Journal of pediatric gastroenterology and nutrition.

[4]  Yaofeng Zhao,et al.  RNAi-based inhibition of porcine reproductive and respiratory syndrome virus replication in transgenic pigs , 2013, Journal of Biotechnology.

[5]  Larissa B. Thackray,et al.  A Mouse Model for Human Norovirus , 2013, mBio.

[6]  R. Jiao,et al.  TALEN or Cas9 - rapid, efficient and specific choices for genome modifications. , 2013, Journal of genetics and genomics = Yi chuan xue bao.

[7]  R. Prather,et al.  Advancing swine models for human health and diseases. , 2013, Missouri medicine.

[8]  W. Paul,et al.  Early signaling events that underlie fate decisions of naive CD4+ T cells toward distinct T‐helper cell subsets , 2013, Immunological reviews.

[9]  R. Akkina,et al.  New generation humanized mice for virus research: comparative aspects and future prospects. , 2013, Virology.

[10]  Lijuan Yuan,et al.  CD4+ CD25− FoxP3+ regulatory cells are the predominant responding regulatory T cells after human rotavirus infection or vaccination in gnotobiotic pigs , 2012, Immunology.

[11]  Lijuan Yuan,et al.  Characterization of immune modulating functions of γδ T cell subsets in a gnotobiotic pig model of human rotavirus infection. , 2012, Comparative immunology, microbiology and infectious diseases.

[12]  Amber D. Miller,et al.  IgA is Important for Clearance and Critical for Protection from Rotavirus Infection , 2012, Mucosal Immunology.

[13]  A. Oxenius,et al.  From crucial to negligible: Functional CD8+ T‐cell responses and their dependence on CD4+ T‐cell help , 2012, European journal of immunology.

[14]  L. Bolund,et al.  Genetically modified pigs for biomedical research , 2012, Journal of Inherited Metabolic Disease.

[15]  F. Clubb,et al.  Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.

[16]  Lijuan Yuan,et al.  High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. , 2012, Vaccine.

[17]  Hans Nauwynck,et al.  The pig: a model for human infectious diseases , 2011, Trends in Microbiology.

[18]  I. Pavlik,et al.  Cell-mediated immune response in swine infected with Mycobacterium avium subsp. avium. , 2011, Veterinary immunology and immunopathology.

[19]  P. Elzer,et al.  B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. , 2011, The Journal of infectious diseases.

[20]  N. Verma,et al.  Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies , 2011, Proteomics.

[21]  B. B. Scott,et al.  Applications of avian transgenesis. , 2010, ILAR journal.

[22]  M. Mendicino,et al.  Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs , 2009, Xenotransplantation.

[23]  W. Gerner,et al.  Porcine T lymphocytes and NK cells--an update. , 2009, Developmental and comparative immunology.

[24]  J. Lunney,et al.  The piglet as a model for B cell and immune system development , 2008, Veterinary Immunology and Immunopathology.

[25]  J. Butler,et al.  The ontogeny of the porcine immune system , 2008, Developmental & Comparative Immunology.

[26]  B. Horvat,et al.  Current animal models: transgenic animal models for the study of measles pathogenesis. , 2009, Current topics in microbiology and immunology.

[27]  L. Saif,et al.  Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs. , 2008, Vaccine.

[28]  M. Estes,et al.  Differential Requirements for T Cells in Viruslike Particle- and Rotavirus-Induced Protective Immunity , 2008, Journal of Virology.

[29]  Y. B. Kim Gnotobiotic miniature swine for immunobiology and medicine , 2007 .

[30]  S. Remy,et al.  Transgenic Modifications of the Rat Genome , 2005, Transgenic Research.

[31]  K. Smetana,et al.  The Miniature Pig as an Animal Model in Biomedical Research , 2005, Annals of the New York Academy of Sciences.

[32]  L. Saif,et al.  Viremia and Nasal and Rectal Shedding of Rotavirus in Gnotobiotic Pigs Inoculated with Wa Human Rotavirus , 2005, Journal of Virology.

[33]  A. Casadevall,et al.  Exploiting the Redundancy in the Immune System , 2003, The Journal of experimental medicine.

[34]  R. Ward Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. , 2003, Viral immunology.

[35]  L. Saif,et al.  Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model , 2002, Veterinary Immunology and Immunopathology.

[36]  Yifan Dai,et al.  Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs , 2002, Nature Biotechnology.

[37]  R. Ward,et al.  CD4 T Cells Are the Only Lymphocytes Needed To Protect Mice against Rotavirus Shedding after Intranasal Immunization with a Chimeric VP6 Protein and the Adjuvant LT(R192G) , 2002, Journal of Virology.

[38]  Yifan Dai,et al.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. , 2002, Nature biotechnology.

[39]  R. Ward,et al.  Role for T cell‐independent B cell activity in the resolution of primary rotavirus infection in mice , 2001, European journal of immunology.

[40]  M. Reitz,et al.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Greenberg,et al.  Immunity to homologous rotavirus infection in adult mice. , 2000, Trends in microbiology.

[42]  H. Greenberg,et al.  Immunity to rotavirus infection in mice. , 1999, The Journal of infectious diseases.

[43]  H. Greenberg,et al.  Immunity to rotavirus in T cell deficient mice. , 1997, Virology.

[44]  L. Saif,et al.  Comparative studies of the pathogenesis, antibody immune responses, and homologous protection to porcine and human rotaviruses in gnotobiotic piglets. , 1997, Advances in experimental medicine and biology.

[45]  L. Saif,et al.  Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. , 1996, The Journal of general virology.

[46]  L. Saif,et al.  Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease , 1996, Journal of virology.

[47]  M. Mehtali,et al.  Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. , 1995, The Journal of general virology.

[48]  A. Bellamy,et al.  Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice , 1991, Journal of virology.

[49]  P. Offit,et al.  Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice , 1990, Journal of virology.

[50]  F. Costantini,et al.  Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis , 1990, Cell.

[51]  T. Sundt,et al.  IN VIVO TREATMENT WITH ANTIPORCINE T CELL ANTIBODIES , 1990, Transplantation.

[52]  R. Ward,et al.  Development of an adult mouse model for studies on protection against rotavirus. , 1990, Journal of virology.

[53]  R. C. Meyer,et al.  Procurement and Maintenance of Germ-Free Swine for Microbiological Investigations , 1964, Applied microbiology.